Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00316420
Recruitment Status : Completed
First Posted : April 20, 2006
Last Update Posted : March 8, 2010
Roche Pharma AG
Information provided by:
Swedish Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2009
  Actual Study Completion Date : August 2009